Search Within

Myeloma

Formats
  1. Meeting Abstract (557)
  2. Journal Article (368)
  3. Review (37)
  4. Research Letter (21)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (7)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (1016)
  2. Department of Medicine (1016)
  3. Hematologic Malignancies, Division of (1016)
  4. Hematologic Malignancies Research (669)
  5. Survivorship Research (374)
  6. Sloan Kettering Institute Postdocs (306)

More Groups

People
  1. Alexander Lesokhin (381)
  2. Hani Hassoun (339)
  3. Carl Landgren (336)
  4. Sham Mailankody (297)
  5. Malin Hultcrantz (274)
  6. Heather Landau (249)

More People

Years
  1. 2025 (28)
  2. 2024 (82)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (317)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (86)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (24)

More Publications

Publishers
  1. American Society of Hematology (340)
  2. Elsevier Inc. (160)
  3. American Society of Clinical Oncology (88)
  4. Nature Publishing Group (87)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (1016)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: A population-based cohort study
    Journal Article

    Hultcrantz, M.; Björkholm, M.; Dickman, P. W.; Landgren, O.; Derolf, Å R.; Kristinsson, S. Y.; Andersson, T. M. L.
    Annals of Internal Medicine (2018)

    Fulltext@MSK | Save
  • Cancer drugs approved based on biomarkers and not tumor type: FDA approval of pembrolizumab for mismatch repair-deficient solid cancers
    Journal Article

    Prasad, V.; Kaestner, V.; Mailankody, S.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
    Journal Article

    Murata, K.; McCash, S. I.; Carroll, B.; Lesokhin, A. M.; Hassoun, H.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Landau, H. J.; Koehne, G.; more...
    Clinical Biochemistry (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in patients with advanced melanoma: Updated survival, response, and safety data in a phase I dose-escalation study
    Journal Article

    Callahan, M. K.; Kluger, H.; Postow, M. A.; Segal, N. H.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J. M.; Krishnan, S.; Bhore, R.; Horak, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical development of PD-1 blockade in hematologic malignancies
    Journal Article

    Pianko, M. J.; Goldberg, A. D.; Lesokhin, A. M.
    The Cancer Journal (2018)

    Fulltext@MSK | Save
  • Prognostic and added value of two-dimensional global longitudinal strain for prediction of survival in patients with light chain amyloidosis undergoing autologous hematopoietic cell transplantation
    Journal Article

    Pun, S. C.; Landau, H. J.; Riedel, E. R.; Jordan, J.; Yu, A. F.; Hassoun, H.; Chen, C. L.; Steingart, R. M.; Liu, J. E.
    Journal of the American Society of Echocardiography (2018)

    Fulltext@MSK | Save
  • A benefit-risk analysis approach to capture regulatory decision-making: Multiple myeloma
    Journal Article

    Raju, G. K.; Gurumurthi, K.; Domike, R.; Kazandjian, D.; Landgren, O.; Blumenthal, G. M.; Farrell, A.; Pazdur, R.; Woodcock, J.
    Clinical Pharmacology & Therapeutics (2018)

    Fulltext@MSK | Save
  • Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma
    Journal Article

    Salem, D. A. R.; Korde, N.; Venzon, D. J.; Liewehr, D. J.; Maric, I.; Calvo, K. R.; Braylan, R.; Tembhare, P. R.; Yuan, C. M.; Landgren, C. O.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
    Journal Article

    Pianko, M. J.; Funt, S. A.; Page, D. B.; Cattry, D.; Scott, E. C.; Ansell, S. M.; Borrello, I. M.; Gutierrez, M.; Lendvai, N.; Hassoun, H.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save